EH66

ICD-11 MMS 2026-01

Fixed drug eruption

Description

The term fixed drug eruption describes the development of one or more annular or oval inflamed erythematous patches on the skin as a result of systemic exposure to a drug. The patches may develop into bullae. The inflamed patches normally resolve with post-inflammatory hyperpigmentation but typically recur at the same site(s), often with progressively more involved sites, following each reexposure to the drug. In extreme cases (generalised bullous fixed drug eruption) the clinical picture may mimic toxic epidermal necrolysis. A large number of drugs have been implicated as triggers.

Index terms

  • Fixed drug eruption
  • Limited fixed drug eruption
  • Generalised bullous fixed drug eruption

Sibling codes

  • EH60 – Exanthematic drug eruption
  • EH61 – Drug-induced urticaria, angioedema or anaphylaxis
  • EH62 – Lichenoid drug eruption
  • EH63 – Stevens-Johnson syndrome or toxic epidermal necrolysis due to drug
  • EH64 – Drug-induced erythroderma
  • EH65 – DRESS syndrome
  • EH67 – Acne or acneiform reactions attributable to drugs
  • EH6Y – Drug eruption of other specified type
  • EH6Z – Drug eruption of unspecified type

Foundation entity

Fixed drug eruption – http://id.who.int/icd/entity/20014644

Allowed postcoordination axes

Part of: 14: Diseases of the skin